Kevin Lofton - Rite Aid Independent Director

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

Fiscal Quarter End: 31st of August 2020  

  Director
Mr. Kevin E. Lofton serves as Independent Director of the Company. He has served as the Chief Executive Officer of Catholic Health Initiatives, a healthcare system operating the full continuum of services from hospitals to home health agencies nationwide since 2003 and as President and CEO of CHI from 2003 through January 2014. Mr. Lofton previously served as Chief Executive Officer of the University of Alabama at Birmingham Hospital and Howard University Hospital in Washington, D.C. Mr. Lofton is also a director and member of the audit and compensation committees of Gilead Sciences, Inc.
Age: 64  Director Since 2013      
717 975-5905  www.riteaid.com

Kevin Lofton Latest Insider Activity

Rite Aid Management Efficiency

Rite Aid has Return on Asset of 1.72 % which means that on every $100 spent on asset it made $1.72 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (53.68) %, meaning that it generated no profit with money invested by stockholders. Rite Aid management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Rite Aid Return on Invested Capital is expected to slightly increase based on the last few years of reporting. The past year's Return on Invested Capital was at 0.07. The current year Return on Sales is expected to grow to 0.0301, whereas Return on Average Assets are expected to decline to (5.45) . Rite Aid Goodwill and Intangible Assets are expected to decrease significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 447.84 Million. The current year Revenue to Assets is expected to grow to 2.98, whereas Assets Non Current are expected to decline to about 3.8 B. Rite Aid Tax Liabilities is expected to increase significantly based on the last few years of reporting. The past year's Tax Liabilities was at 66.34 Million
The company has 6.53 B in debt. Rite Aid has a current ratio of 1.44, which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

DIRECTOR Since

Kenneth AmbrechtSpectrum Brands Holdings
2018
John HinshawSysco
2018
Sherianne JamesSpectrum Brands Holdings
2018
Nelson PeltzSysco
2015
Lawrence MolloySprouts Farmers Market
2019
Diana FergusonSally Beauty Holdings
2019
Jacky XuVipshop Holdings Limited
2008
Nancy NewcombSysco
2006
Paul BrownJ C Penney
2016
Monica LozanoTarget
2016
Terry PolistinaSpectrum Brands Holdings
2018
Douglas BakerTarget
2014
Wonya LucasJ C Penney
2017
Lau PingVipshop Holdings Limited
2017
George BarrettTarget
2018
Terri GrahamSprouts Farmers Market
2013
Kathleen ChienVipshop Holdings Limited
2012
John CassadaySysco
2004
Susan MulderSally Beauty Holdings
2014
Calvin DardenTarget
2003
Stephen SadoveJ C Penney
N/A

Company Summary

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in the United States and is traded on BATS Exchange. It employs 29840 people.Rite Aid (RAD) is traded on BATS Exchange in USA and employs 29,840 people.

Rite Aid Leadership Team

Heyward Donigan, President, Chief Executive Officer, Director
Joseph Anderson, Independent Director
Elizabeth Burr, Independent Director
Douglas Donley, Chief Accounting Officer, Senior Vice President
Jim Peters, Chief Operating Officer
Michael Regan, Lead Independent Director
Arun Nayar, Independent Director
Brian Hoover, Chief Accounting Officer
David Jessick, Independent Director
Katherine Quinn, Independent Director
Myrtle Potter, Director
Bruce Bodaken, Independent Chairman of the Board
Kevin Lofton, Independent Director
Matt Schroeder, Group Vice President Strategy, Investor Relations and Treasurer
David Abelman, Executive Vice President - Marketing
Frank Savage, Independent Director
Kermit Crawford, President COO
Marcy Syms, Independent Director
James Comitale, Senior Vice President General Counsel, Secretary
Steve Rempel, Senior Vice President CIO
Justin Mennen, Senior Vice President, Chief Information Officer
Dedra Castle, Chief Human Resource Officer, Executive Vice President
Erik Keptner, Senior Vice President Chief Marketing Officer
Marc Strassler, Corporate Counsel
Kenneth Martindale, Pres and CEO of Rite Aid Stores
Derek Griffith, Executive Vice President - Store Operations
Enio Montini, Executive Vice President - Merchandising
Louis Miramontes, Independent Director
Darren Karst, CFO, Chief Admin. Officer and Sr. Executive VP
Jocelyn Konrad, Executive Vice President - Pharmacy and Retail Operations
Matthew Schroeder, Chief Financial Officer, Senior Vice President
Robert Knowling, Independent Director
Andre Persaud, Executive Vice President - Retail
Bryan Everett, Executive Vice President - Store Operations
Doug Donley, Chief Accounting Officer, Senior Vice President
John Standley, Chairman, CEO and Chairman of Executive Committee
James Peters, Chief Operating Officer

Stock Performance Indicators

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Currently Active Assets on Macroaxis

S   
Sold over 300 shares of
22 hours ago
Traded for 8.62
GM   
Sold over 100 shares of
22 hours ago
Traded for 25.24
XOM   
Sold over 60 shares of
22 hours ago
Traded for 44.08
OTPBF   
Sold over 100 shares of
22 hours ago
Traded for 28.82
MSFT   
Sold few shares of
22 hours ago
Traded for 206.26
Additionally, take a look at Your Equity Center. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page